Experienced in Primary Biliary Cholangitis

Dr. Emil Valle

Gastroenterology
Gastroenterology Associates Of Northern Virginia, LLC
1939 Roland Clarke Pl, Suite 200, 
Reston, VA 
Offers Telehealth
Experienced in Primary Biliary Cholangitis
Gastroenterology Associates Of Northern Virginia, LLC
1939 Roland Clarke Pl, Suite 200, 
Reston, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emil Valle is a Gastroenterologist in Reston, Virginia. Dr. Valle is rated as an Experienced provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Ulcerative Colitis, Colitis, Familial Adenomatous Polyposis, Gastrectomy, and Endoscopy.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in VA
Hospital Affiliations
Reston Hospital Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Innovation Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

GASTROENTEROLOGY ASSOCIATES OF NORTHERN VIRGINIA, LLC
1939 Roland Clarke Pl, Suite 200, Reston, VA 20191
Other Locations
GASTROENTEROLOGY ASSOCIATES OF NORTHERN VIRGINIA, LLC
3022 Williams Dr, Suite 301, Fairfax, VA 22031

Additional Areas of Focus

Dr. Valle has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Distinguished in Primary Biliary Cholangitis
Dr. Zobair M. Younossi
Gastroenterology
Distinguished in Primary Biliary Cholangitis
Dr. Zobair M. Younossi
Gastroenterology

Inova Fairfax Hospital Center For Liver Diseases

3300 Gallows Rd Medicine, 
Falls Church, VA 
 (10.0 miles away)
703-776-2540
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Zobair Younossi is a Gastroenterologist in Falls Church, Virginia. Dr. Younossi is rated as an Elite provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Hepatitis C, Liver Transplant, and Heart Transplant. Dr. Younossi is currently accepting new patients.

Distinguished in Primary Biliary Cholangitis
Dr. Paul Thuluvath
Gastroenterology
Distinguished in Primary Biliary Cholangitis
Dr. Paul Thuluvath
Gastroenterology

St Paul Place Specialists Inc

301 Saint Paul St, 
Baltimore, MD 
 (46.0 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Thuluvath is a Gastroenterologist in Baltimore, Maryland. Dr. Thuluvath is rated as an Elite provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Liver Failure, Cirrhosis, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy.

Distinguished in Primary Biliary Cholangitis
Dr. Darryn Potosky
Gastroenterology
Distinguished in Primary Biliary Cholangitis
Dr. Darryn Potosky
Gastroenterology

Capital Digestive Care LLC

5500 Knoll N Dr, Suite 460, 
Columbia, MD 
 (33.2 miles away)
410-730-9363
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Darryn Potosky is a Gastroenterologist in Columbia, Maryland. Dr. Potosky is rated as an Advanced provider by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Primary Biliary Cholangitis, Reynolds Syndrome, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Thrombectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Valle's expertise for a condition
ConditionClose
    View All 33 Advanced Conditions
    View All 69 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile